We are live on ! Find out more
BC

Bartlett & Co Portfolio holdings

AUM $6.16B
1-Year Est. Return 20.29%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.78B
AUM Growth
+$604M
Cap. Flow
+$315M
Cap. Flow %
5.44%
Top 10 Hldgs %
30.92%
Holding
1,221
New
145
Increased
296
Reduced
158
Closed
48

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$21.8M
2
AAPL icon
Apple
AAPL
+$17.5M
3
UNH icon
UnitedHealth
UNH
+$13.1M
4
TMO icon
Thermo Fisher Scientific
TMO
+$12.6M
5
CFR icon
Cullen/Frost Bankers
CFR
+$12.2M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$18.1M
2
VCIT icon
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
+$4.79M
3
USB icon
US Bancorp
USB
+$4.28M
4
CMCSA icon
Comcast
CMCSA
+$4.22M
5
TROW icon
T. Rowe Price
TROW
+$4.17M

Sector Composition

Rank Sector Weight
1 Technology 19.66%
2 Miscellaneous 17.21%
3 Healthcare 12.66%
4 Financials 11.11%
5 Industrials 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZUO
801
DELISTED
Zuora, Inc.
ZUO
$22K ﹤0.01%
2,000
– –
JPS
802
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$22K ﹤0.01%
3,458
– –
ARR.PRC
803
ARMOUR Residential REIT Series C
ARR.PRC
$141M
$21K ﹤0.01%
+1,000
New +$19.9K
HLI icon
804
Houlihan Lokey
HLI
$9.47B
$21K ﹤0.01%
217
– –
RBC icon
805
RBC Bearings
RBC
$15.4B
$21K ﹤0.01%
96
– –
RCL icon
806
Royal Caribbean
RCL
$69.6B
$21K ﹤0.01%
200
– –
RPTX
807
DELISTED
Repare Therapeutics
RPTX
$21K ﹤0.01%
2,000
– –
C.PRK
808
DELISTED
Citigroup Inc. Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 6.875% Fixed Rate/Floating Rate Noncumulative Preferred Stock, Series K
C.PRK
$21K ﹤0.01%
835
– –
ALL.PRH icon
809
Allstate Corp
ALL.PRH
$850M
$20K ﹤0.01%
900
– –
BKN
810
DELISTED
BlackRock Investment Quality Municipal Trust
BKN
$20K ﹤0.01%
1,700
– –
BWA icon
811
BorgWarner
BWA
$13.3B
$20K ﹤0.01%
454
– –
ENR icon
812
Energizer
ENR
$1.37B
$20K ﹤0.01%
+600
New +$20K
IWC icon
813
iShares Micro-Cap ETF
IWC
$1.45B
$20K ﹤0.01%
185
– –
PIO icon
814
Invesco Global Water ETF
PIO
$265M
$20K ﹤0.01%
547
– –
NEWR
815
DELISTED
New Relic, Inc.
NEWR
$20K ﹤0.01%
308
+42
+16% +$3.03K
ALNY icon
816
Alnylam Pharmaceuticals
ALNY
$34.2B
$19K ﹤0.01%
100
– –
DRH.PRA
817
DELISTED
DiamondRock Hospitality Co 8.250% Series A Preferred Stock
DRH.PRA
$19K ﹤0.01%
+726
New +$18.7K
FBCG
818
Fidelity Blue Chip Growth ETF
FBCG
$7.36B
$19K ﹤0.01%
640
– –
LSTR icon
819
Landstar System
LSTR
$5.9B
$19K ﹤0.01%
101
– –
POR icon
820
Portland General Electric
POR
$5.73B
$19K ﹤0.01%
400
– –
SPMD icon
821
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.4B
$19K ﹤0.01%
424
– –
UNM icon
822
Unum
UNM
$14.7B
$19K ﹤0.01%
392
– –
WDC icon
823
Western Digital
WDC
$176B
$19K ﹤0.01%
+662
New +$18.4K
HR
824
DELISTED
Healthcare Realty Trust Incorporated
HR
$19K ﹤0.01%
+1,000
New +$19K
AAL icon
825
American Airlines Group
AAL
$8.53B
$18K ﹤0.01%
1,000
-800
-44% -$11.7K
31 32
33
34 35

Similar funds

WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return

Bartlett & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Bartlett & Co held 1,221 positions worth $5.78B, up 12% from $5.18B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bartlett & Co deployed $315M of net new capital in Q2 2023, opening 145 new positions and adding to 296 existing holdings. Its largest new stake was Toro Company: 25,480 shares worth $2.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $18.1M trimmed.

  • Bartlett & Co's largest Q2 2023 buy was Toro Company: 25,480 shares worth $2.6M.
  • Bartlett & Co added most to Chevron in Q2 2023, an estimated $21.8M increase.
  • Bartlett & Co's biggest Q2 2023 reduction was Bristol-Myers Squibb, cutting an estimated $18.1M.
  • Bartlett & Co fully exited iPath Pure Beta Broad Commodity ETN in Q2 2023, selling an estimated $684K.
  • Bartlett & Co's ten largest holdings make up 31% of its $5.78B portfolio in Q2 2023.
  • Bartlett & Co opened 145 new positions and closed 48 in Q2 2023.
  • Bartlett & Co's portfolio value rose 12% quarter-over-quarter to $5.78B.

Based on Bartlett & Co's 13F filing for Q2 2023, filed 14 Jul 2023.